1. Taketomo C, Hodding J, Kraus D. Pediatric & neonatal dosage handbook. 21st ed. United States of America: Lexicomp; 2014.
2. BC Cancer Agency Drug Manual: Brentuximab vedotin. 2016.
http://www.bccancer.bc.ca/drug-database-site/drug%20index/brentuximab%20vedotin_monograph_1mar2016.pdf
. Accessed 18 June 2018.
3. Roche. Product monograph: Avastin. 2018.
http://www.rochecanada.com/content/dam/roche_canada/en_CA/documents/Research/ClinicalTrialsForms/Products/ConsumerInformation/MonographsandPublicAdvisories/Avastin/Avastin_PM_E.pdf
. Accessed 20 June 2018.
4. Fangusaro J, Gururangan S, Poussaint TY. Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and Irinotecan (CPT-11): A Pediatric Brain Tumor Consortium Study (PBTC-022). Cancer. 2013.
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.28343
. Accessed 20 June 2018.
5. FDA. Prescribing information: Blenoxane.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/050443s036lbl.pdf. Accessed 9 Oct 2018
.